Director, SEE REMARKS · Forte Biosciences, Inc. · Forte Biosciences, Inc. — Restricted Stock Units
Side
A
Value
—
Shares
180.0K
Price
—
Executed
Jan 12, 2026
Disclosed
Jan 13, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 12 executedJan 13, 2026 disclosed
FBRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Wagner Paul A. filed this Form 4 reporting a grant or award of FBRX on Jan 12, 2026. It became public on Jan 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, SEE REMARKS
Wagner Paul A.cik:0001612842
Issuer
Forte Biosciences, Inc.cik:0001419041
Revision history · 0
No field has changed since this record was first ingested.
